Wed, September 5, 2012
[ Wed, Sep 05th 2012 ]: Market Wire
Johnson amp;; Johnson to Participate in Morgan Stanley Global Health Care Conference
[ Wed, Sep 05th 2012 ]: Market Wire
Securities Lawyers Seeking More Money, Information for Stockholders of Medicis at Goldfarb LLP
[ Wed, Sep 05th 2012 ]: Market Wire
Salix Pharmaceuticals Outlines Data Presentations at PAINWeek
[ Wed, Sep 05th 2012 ]: Market Wire
XenoPort to Present at the Morgan Stanley Global Healthcare Conference
[ Wed, Sep 05th 2012 ]: Market Wire
Aetna and NovaHealth Work Together to Reduce Hosp .. tions, Lower Costs for Medicare Advantage Members
[ Wed, Sep 05th 2012 ]: Market Wire
Vivakor Announces Acquisition of Royalty Stream a .. bal LLC. and the Addition of Tom Lee to the Board
[ Wed, Sep 05th 2012 ]: Market Wire
U.K.'s National Institute for Health and Clinical .. limera Sciences' ILUVIEN Subgroup Data for Review
[ Wed, Sep 05th 2012 ]: Market Wire
biOasis's Herceptin(R)-BT2111 Stops Human Breast Cancer Tumor Growth in Animals
[ Wed, Sep 05th 2012 ]: Market Wire
Baxter Hosting Investor Conference on October 9, 2012
[ Wed, Sep 05th 2012 ]: Market Wire
Extendicare Announces Increase of Previously Anno .. ffering to $110 million of Convertible Debentures
[ Wed, Sep 05th 2012 ]: Market Wire
Targacept Announces Plans to Develop TC-5214 in Overactive Bladder
[ Wed, Sep 05th 2012 ]: Market Wire
ACADIA Pharmaceuticals Announces Completion of En .. serin Trial in Parkinson’s Disease Psyc
[ Wed, Sep 05th 2012 ]: Market Wire
High-Quality Care Can Be 14 Percent More Affordab .. on Average, but with Significant Local Variations
[ Wed, Sep 05th 2012 ]: Market Wire
InSite Vision Introduces DuraSite 2®; Ophthalmic Drug Delivery System
[ Wed, Sep 05th 2012 ]: Market Wire
Rienso®; (Ferumoxytol) Receives Swiss Mark .. reatment of Iron Deficiency Anemia in Adult Patie
[ Wed, Sep 05th 2012 ]: Market Wire
NPS Pharmaceuticals Expects to File Natpara™ BLA in Mid-2013
[ Wed, Sep 05th 2012 ]: Market Wire
Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for Discoid Lupus
[ Wed, Sep 05th 2012 ]: Market Wire
Synageva BioPharma to Present at Upcoming Investor Conferences
[ Wed, Sep 05th 2012 ]: Market Wire
Arrowhead to Present at Rodman and Renshaw Annual Global Investment Conference
[ Wed, Sep 05th 2012 ]: Market Wire
FDA Continues Review of Crofelemer New Drug Appli .. ation beyond PDUFA Goal Date of September 5, 2012
[ Wed, Sep 05th 2012 ]: Market Wire
Shareholder Rights Law Firm Johnson & Weaver, LLP .. tes Assisted Living Concepts for Securities Fraud
[ Wed, Sep 05th 2012 ]: Market Wire
Auxilium Pharmaceuticals, Inc. Announces 30 Month XIAFLEX Safety Update
[ Wed, Sep 05th 2012 ]: Market Wire
Sequenom Announces Participation At The Morgan Stanley Global Healthcare Conference
[ Wed, Sep 05th 2012 ]: Market Wire
Implant Sciences Explosives and Narcotics Trace D .. s to Be Shown at Major European Police Exhibition
Tue, September 4, 2012
[ Tue, Sep 04th 2012 ]: Market Wire
GeoVax to Present at the Rodman &;; Renshaw 2012 Annual Global Investment Conference
[ Tue, Sep 04th 2012 ]: Market Wire
BioSante Pharmaceuticals Announces Positive LibiG .. Data Review and Decision to Conclude the Safety S
[ Tue, Sep 04th 2012 ]: Market Wire
PhotoMedex to Participate in Two Investment Conferences During September
[ Tue, Sep 04th 2012 ]: Market Wire
Allergan Opens New Research and Development Center in Bridgewater, New Jersey
[ Tue, Sep 04th 2012 ]: Market Wire
Cubist Appoints Patrick Vink as Senior Vice Presi .. ent and General Manager of International Business
[ Tue, Sep 04th 2012 ]: Market Wire
Thermo Fisher Scientific to Present at Morgan Sta .. lobal Healthcare Conference on September 11, 2012
[ Tue, Sep 04th 2012 ]: Market Wire
Youth Are Invited to “Step into Service .. as UnitedHealth HEROES to Fight Childhood Obesity
[ Tue, Sep 04th 2012 ]: Market Wire
Cerus Announces INTERCEPT Blood System for Platel .. egulatory Submission for Approval in South Africa
[ Tue, Sep 04th 2012 ]: Market Wire
CytRx to Present at the Rodman & Renshaw 14th Annual Global Investment Conference
[ Tue, Sep 04th 2012 ]: Market Wire
ACT’s Chief Scientific Officer Dr. Robe .. Keynote Address at 4th Annual Stem Cell Symposium
[ Tue, Sep 04th 2012 ]: Market Wire
Vertex Announces Appointment of Stuart A. Arbuckle as Chief Commercial Officer
[ Tue, Sep 04th 2012 ]: Market Wire
Amica Mature Lifestyles Increases Ownership in Amica at Bearbrook
[ Tue, Sep 04th 2012 ]: Market Wire
Immunovaccine to Present at Rodman &;; Renshaw 14th Annual Global Healthcare Conference
[ Tue, Sep 04th 2012 ]: Market Wire
Impax Laboratories Announces Settlement of Litiga .. Relating to RENVELA®; and RENAGEL®;
[ Tue, Sep 04th 2012 ]: Market Wire
Durata Therapeutics, Inc. Reports Second Quarter 2012 Financial and Corporate Results
[ Tue, Sep 04th 2012 ]: Market Wire
ARIAD to Present at Upcoming Investor Conferences
[ Tue, Sep 04th 2012 ]: Market Wire
Mylan Selected as a Leading ARV Supplier to India's National AIDS Control Organization
[ Tue, Sep 04th 2012 ]: Market Wire
Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
[ Tue, Sep 04th 2012 ]: Market Wire
Marquette General Joins Duke LifePoint
[ Tue, Sep 04th 2012 ]: Market Wire
Codexis Appoints David O’Toole as Chief Financial Officer
[ Tue, Sep 04th 2012 ]: Market Wire
NanoViricides Reports that Oral Administration of .. nza Drug Candidates Led to Strong Antiviral Antib
[ Tue, Sep 04th 2012 ]: Market Wire
BioLineRx In-Licenses a Novel, Phase II Ready Dru .. tment of Leukemia and Other Hematological Cancers
[ Tue, Sep 04th 2012 ]: Market Wire
Omeros to Present at the 19th Annual Newsmakers in the Biotech Industry Conference
[ Tue, Sep 04th 2012 ]: Market Wire
Sequenom Welcomes Myla Lai-Goldman, M.D., To Board Of Directors

Biogen Idec to Present at the Morgan Stanley Global Healthcare Unplugged Conference

WESTON, Mass.--([ ])--Biogen Idec Inc. (NASDAQ: BIIB) announced today that its presentation at the Morgan Stanley Global Healthcare Unplugged Conference will be webcast live on Monday, September 10, 2012 at 1:50 p.m. ET. To access the live webcast, please visit Biogen Idecas Investor Relations section ([ www.investor.biogenidec.com ]). An archived version of the webcast will be available for 14 days following the presentation.

About Biogen Idec

Through cutting-edge science and medicine, Biogen Idec discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. Founded in 1978, Biogen Idec is the worldas oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates more than $5 billion in annual revenues. For product labeling, press releases and additional information about the company, please visit [ www.biogenidec.com ].